Key clinical point: Stratifying nonobstructive coronary disease by invasive testing during angiography led to better patient management and improved outcomes.
Major finding: Patients managed by clinicians aware of the full diagnostic results had blood pressures that averaged 12/5 mm Hg below those of controls after 1 year.
Study details: CorMicA, a two-center, randomized study of 151 patients with stable angina and nonobstructive coronary disease.
Disclosures: Dr. Berry has been a speaker on behalf of Abbott Vascular, and he has received research funding from AstraZeneca, GlaxoSmithKline, HeartFlow, Novartis, and Siemens Healthcare. Dr. Reynolds had no disclosures.
Ford TJ. AHA scientific sessions abstract.